Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neuromuscular Mechanisms and Oxidative Stress in Skeletal Muscle Atrophy: Emerging Stem Cell and Gene-Based Therapeutic Strategies. | Muscles | 2026 | 41718080 | PubTator, text mining | PubMed |
| Anti-cancer effect of palmitic acid against the endometrial cancer progression via inducing ferroptosis. | Biochem Biophys Rep | 2026 | 41717082 | PubTator, text mining | PubMed |
| Cord serum metabolic signatures associated with neonatal anthropometry and neurodevelopment through age two in twins. | iScience | 2026 | 41717000 | PubTator, text mining | PubMed |
| The role and mechanism of IL‑35 in myasthenia gravis (Review). | Int J Mol Med | 2026 | 41716022 | PubTator, text mining | PubMed |
| A Case Report of Guillain-Barré Syndrome Presenting as Facial Diplegia: A Deviation From the Classical Ascending Paralysis. | Cureus | 2026 | 41710842 | PubTator, text mining | PubMed |
| Case Report: Immunotherapy-induced myocarditis requiring pacemaker insertion in an older adult. what happens if we rechallenge? | Front Oncol | 2026 | 41710664 | PubTator, text mining | PubMed |
| Successful Plasma Exchange and Steroid Maintenance Therapy for Severe Pembrolizumab-Induced Polyradiculoneuritis in Lung Cancer: A Case Report. | Case Rep Oncol | 2026 | 41710645 | PubTator, text mining | PubMed |
| Rapid efficacy of efgartigimod for generalized myasthenia gravis patients in acute exacerbations/worsening: multicenter real-world retrospective study. | J Neurol | 2026 | 41699286 | PubTator, text mining | PubMed |
| Longitudinal MuSK antibody levels may correlate with disease severity in MuSK myasthenia gravis. | J Neuroimmunol | 2026 | 41653839 | PubTator, text mining | PubMed |
| Delayed recovery following myasthenic exacerbation and subsequent endplate-protecting treatment. | Neurol Sci | 2026 | 41634421 | PubTator, text mining | PubMed |
| PGVDA: a pathway-aggregated genetic dosage framework for interpretable disease classification using machine learning. | Brief Bioinform | 2026 | 41632594 | PubTator, text mining | PubMed |
| [Myasthenic syndromes: retrospective analysis of two patient cohorts]. | Fortschr Neurol Psychiatr | 2026 | 41628617 | PubTator, text mining | PubMed |
| Neuromuscular Junction as a Molecular Target in Sarcopenia: Mechanisms, Therapeutic Strategies, and Future Directions. | Mol Diagn Ther | 2026 | 41619083 | PubTator, text mining | PubMed |
| Exploring Pembrolizumab-Induced IM3OS in a Patient With Bladder Cancer. | Pharmacol Res Perspect | 2026 | 41582708 | PubTator, text mining | PubMed |
| A Validated Transcriptomic NMJ Remodeling Score Reveals Synaptic Dysfunction Independent of Muscle Atrophy after Immobilization in a Microgravity Analog. | Neuroinformatics | 2026 | 41579264 | PubTator, text mining | PubMed |
| Exploring molecular signatures in PURA syndrome using muscle proteomics and serum biomarkers. | J Neurol | 2026 | 41575592 | PubTator, text mining | PubMed |
| Antibodies to watch in 2026. | MAbs | 2026 | 41560619 | PubTator, text mining | PubMed |
| CAR-T cell therapy: A new dawn in the treatment of autoimmune disease. | Cell Transplant | 2026 | 41558532 | PubTator, text mining | PubMed |
| Fiber-type-specific architecture and pathophysiology of the neuromuscular junction. | Neuroscience | 2026 | 41548740 | PubTator, text mining | PubMed |
| Co-Occurrence of Myasthenia Gravis and Facioscapulohumeral Muscular Dystrophy: A Case Series and Review of Literature. | Eur J Neurol | 2026 | 41542987 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=5